US20130040403A1 - Method and apparatus for automated analysis - Google Patents

Method and apparatus for automated analysis Download PDF

Info

Publication number
US20130040403A1
US20130040403A1 US13/568,965 US201213568965A US2013040403A1 US 20130040403 A1 US20130040403 A1 US 20130040403A1 US 201213568965 A US201213568965 A US 201213568965A US 2013040403 A1 US2013040403 A1 US 2013040403A1
Authority
US
United States
Prior art keywords
sample
analyte
substance
pretreatment
subsample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/568,965
Inventor
Sari TIKANOJA
Annu SUONIEMI-KÄHÄRÄ
Johan FINELL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thermo Fisher Scientific Oy
Original Assignee
Thermo Fisher Scientific Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thermo Fisher Scientific Oy filed Critical Thermo Fisher Scientific Oy
Priority to US13/568,965 priority Critical patent/US20130040403A1/en
Assigned to THERMO FISHER SCIENTIFIC OY reassignment THERMO FISHER SCIENTIFIC OY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FINELL, JOHAN, SUONIEMI-KAHARA, ANNU, TIKANOJA, SARI
Publication of US20130040403A1 publication Critical patent/US20130040403A1/en
Priority to US15/681,702 priority patent/US10845278B2/en
Priority to US17/073,426 priority patent/US20210033503A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G01N1/31—Apparatus therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/405—Concentrating samples by adsorption or absorption
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
    • G01N35/025—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations having a carousel or turntable for reaction cells or cuvettes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
    • G01N35/04—Details of the conveyor system
    • G01N2035/0439—Rotary sample carriers, i.e. carousels
    • G01N2035/0441—Rotary sample carriers, i.e. carousels for samples
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
    • G01N35/04—Details of the conveyor system
    • G01N2035/0439—Rotary sample carriers, i.e. carousels
    • G01N2035/0443—Rotary sample carriers, i.e. carousels for reagents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
    • G01N35/04—Details of the conveyor system
    • G01N2035/0439—Rotary sample carriers, i.e. carousels
    • G01N2035/0444—Rotary sample carriers, i.e. carousels for cuvettes or reaction vessels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N2035/1027—General features of the devices
    • G01N2035/1032—Dilution or aliquotting
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/0098—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor involving analyte bound to insoluble magnetic carrier, e.g. using magnetic separation

Definitions

  • the present invention relates to method and apparatus for automated sample treatment for automated discrete fluid analyzer
  • Automated instruments for various kind of chemical analysis have been widely used for decades. They may combine both routine and sophisticated assay techniques such as spectrophotometry, fluorometry, time resolved fluorometry, chromatographic methods etc. with automated sample dispensing from original sample containers. Automation is often required as test workload increases within healthcare and clinical laboratories, public or commercial research and service institutes, or industrial process control.
  • a computer controlled robotic arm may be used to position a probe of a pipettor to aspirate or deposit a fluid sample, buffer or reagent into or out of any of a plurality of sample receptacles, a plurality of reagent receptacles and a plurality of reaction cuvettes.
  • This is a “discrete” analysis technique because each sample is deposited in a discrete reaction cuvette, which is then subjected to an assaying device such as colorimetric photometer, or the like.
  • an assaying device such as colorimetric photometer, or the like.
  • several discrete analyses may be done on subsamples divided from a main sample placed on a receptacle. For example, from a serum sample, a panel of serum lipids (triglyserides, cholesterol and HDL-cholesterol) can be measured.
  • sample types are not ready for assay as collected and, instead, require a pretreatment step.
  • plasma or serum must be separated from whole blood; whole blood must be hemolyzed to release intracellular components; fecal, sputum or solid tissue samples must be homogenized and suspended in liquids.
  • interfering proteins must be precipitated, or analytes extracted from the original sample matrix. So while automatic analyzers have significantly improved throughput rate of analytical testing service, manual sample pretreatment has become a primary bottleneck in daily work flow.
  • Sample pretreatment is often considered as a separate process from the actual assay and, therefore, not well suited to instruments streamlined to perform one type of analytical process or measurement quickly and efficiently.
  • Pretreatments are designed according to sample matrix and nature of analyte, and are usually not bound to particular assay principles. This may explain the lack of pretreatment automation, as sample oriented additional steps preceeding the chemical assay reaction would lower throughput and cause difficulty in timing of assay sequences.
  • a sample of whole blood is hemolyzed within a discrete photometric analyzer to release the hemoglobin molecules from within blood cells. Hemolyzation is carried out by mixing whole blood with hemolyzing reagent in a reaction vessel or a cuvette and incubating the mixture for a defined time. After hemolyzation, an aliquot of the mixture is sampled to measure HbAlc content with a turbidimetric inhibition immunoassay and another aliquot is sampled to measure total hemoglobin content. In such method, the analytes and matrix components are not separated prior to the analyzing. This kind of analysis can be performed by KonelabTM clinical chemistry analyzers (Thermo Fisher Scientific), for example.
  • nitrate (NO3-) is reduced to nitrite (NO2-) using Cd2+ granules as catalyst.
  • the reduction is accomplished by aspirating sample to the column where the reduction takes place and then eluting the reduced sample to a vessel. From the vessel an aliquot is sampled to measure nitrite.
  • This kind of analysis can be performed by an AquakemTM analyzer (Thermo Fisher Scientific). In this system analytes undergo a chemical reaction during the pretreatment; there is no means for separating reacted from unreacted or other non-target analytes.
  • the nitrate reduction to nitrite can also be performed in a reaction vessel.
  • US 2009/0162942 discloses an automated discrete fluid sample analyzer that includes a sample preparation module.
  • the sample preparation module includes a well configured to receive a sample deposited by a pipettor and a sample preparation device in fluid communication with the well.
  • the fluid sample is transferred from the well to the sample preparation device which prepares the sample by using catalyst, ultraviolet light or heat.
  • the target analyte is not separated from the sample.
  • the present invention provides a novel approach to arrange integrated pretreatment for automated discrete analyzing apparatus.
  • an integrated pretreatment step comprising selectively either a pretreatment wherein at least one matrix substance is retained from a sample volume without chemically changing the chemical composition of the analyte or the sample is left untreated, whereafter one or more analysis are performed on the sample.
  • the measurements are performed with a discrete fluid analyzer that performs chemical reactions and photometric measurements in single/separate wells.
  • the measurement is at least one of the group comprising photometric measurement or electrochemical measurement.
  • At least two different measurements are performed on subsamples of one sample; either after a pretreatment is performed, without performing the pretreatment or both.
  • dispensing and transportation of subsamples of an analyte sample volume is performed with anon-disposable or an on board washable dispenser or dispenser tip.
  • At least one measurement is performed on pretreated or not pretreated subsample (sample aliquot) without reacting the subsample chemically.
  • At least one measurement is performed on pretreated or not pretreated subsample (sample aliquot) after adding at least one reagent thereto.
  • At least one matrix substance or analyte is retained from the sample volume by capture means wherefrom it is reversibly removable.
  • the matrix substance or analyte that is retained is eluted or regenerated from the capture means for measurement.
  • analyte is retained.
  • the analyte is retained by a method that is chemically inactive in relation to the analyte that is measured from the pretreated volume.
  • the invention provides a method wherein the analyte to be measured is retained by immobilization.
  • the invention utilizes a surface that immobilizes the substance that is to be measured.
  • At least one embodiment of the invention enables to enrich analytes. Enrichment is needed when the concentration of analytes in the sample is too low for the measurement. This can be done by retaining the analytes in, for example a column, or other suitable apparatus, and eluting them in a volume that is smaller than the initial volume.
  • At least one embodiment of the invention enables the separation of analytes and matrix components that interfere with the analyte measurement. This is done either by retaining the analytes in a column or other suitable apparatus, and washing matrix components out before analyte elution, or by retaining the matrix components in the column and washing the analytes out before matrix elution.
  • At least one embodiment of the invention is applicable to fractionation of analytes into different fractions. This is done by retaining the analytes in the column or on other substrates, and eluting the analytes in fractions by using eluents with increasing elution strength.
  • Isolation and/or concentration of analytes from a sample can be achieved by using one of the following methods, or any combination of two or more, including but not limited to:
  • the modes by which the retention is accomplished include, but is not limited to, reversible covalent bonding, ionic interaction, sieving or filtering (molecular size and shape, diffusion), polarity, hydrophobicity, molecule or group specific interaction and chiral recognition.
  • the invention in one aspect, is an automated discrete fluid analyzing device providing sample pretreatment wherein at least one substance of the sample matrix or analyte is retained.
  • the invention is an automated discrete photometric analyzing device providing sample pretreatment wherein at least one substance of the sample matrix or analyte is retained.
  • At least one substance is retained by immobilizing it to a solid support and eluting it from the solid support for analysis and/or measurement.
  • the retained substance is removed from the sample and not subjected to analysis.
  • At least one substance is retained from the sample by a filtration method, such as membrane filtration or a gel filtration.
  • the at least one substance is retained by immobilization on a solid support.
  • the at least one substance is retained by immobilization by an antibody.
  • the at least one substance is retained by one or more of following methods: reversible covalent bonding, ionic interaction, sieving or filtering (molecular size and shape, diffusion), polarity, hydrophobicity, molecule or group specific interaction and chiral recognition.
  • Sample pretreatment process contains Analyte(s) of interest (A), Interfering (I) and Other substances (O) and water or other Fluid (F).
  • A Analyte(s) of interest
  • I Interfering
  • O Other substances
  • F water or other Fluid
  • subsample is taken and automatically pretreated to bring the unaltered analyte of interest (A) to the discrete photometric analysis.
  • Component(s) Component(s) removed retained from the in the pretreat pretreatment treatment Samples for the discrete photometric No Sample unit unit analysis 1 A + F + I + O A (Analyte) I + F + O Analyte is concentrated and/or purified in the pretreatment phase. In the measurement phase analyzer can automatically calculate its original concentration in the sample. Analyte remains intact throughout the process.
  • a + F + I + O I Interfering A + F + O Sample is pretreated to clean the substance) interfering substances. Interfering substance(s) (I) are retained in the pretreatment unit. Unaltered analyte is transferred eg. into a secondary sample holder and further directed to analysis. Thereafter the capturing device is regenerated and elution and regeneration liquids are descarded. Analyte of interest (A) can be calculated to the original concentration in the sample after the discrete photometer measurement for the specific analyte.
  • a + F + I + O Sample is Sample can also be analyzed as such not without the pretreatment step directed to the pretreatment unit 4 A + F + I + O Two or more pretreatments in any order
  • FIG. 1 shows diagrammatically an automated discrete fluid analyzing device to which the invention is implemented.
  • FIG. 2 shows diagrammatically one embodiment of a pretreatment unit for device in FIG. 1 .
  • FIG. 3 shows a flow diagram of one operation workflow of the invention.
  • FIG. 4 shows an explanatory screen display of an apparatus utilizing the invention.
  • Separate step from analysis chemistry provides eg. a concentrated, fractionated or purified analyte.
  • pretreatment may be modifying or non-modifying in relation to the substance to be pretreated.
  • Discrete fluid analyzer performs chemical reactions and photometric measurements in single/separate wells.
  • an analyzer contains multiple wells in which different reactions are ongoing simultaneously. Several different tests may be requested from each sample. Also different types of samples may be analyzed simultaneously.
  • Column is typically a cylindrical or other formed vessel to which liquid samples and reagents may be introduced and analytes and/or other components eluted.
  • the column may be in-line connected to a pump or syringe in which case the samples and reagents are pumped to and from the column using positive or negative pressure. Or the column may be freely diffusing in which case samples and reagents are drawn to and from the column by gravity or by centrifugal force.
  • the column may be packed or lined with material that has affinity towards the analytes or matrix components. As an alternative, the column may be packed with material that functions as a sieve or filter. Physical treatments may also be connected to the column.
  • the column may be single use (disposable) or reusable.
  • sample A whole sample as collected is a “sample” or “primary sample”.
  • primary sample The part of the sample that is pretreated, is a “sub sample”.
  • the substances that are analyzed are analytes. All other components in a sample are matrix.
  • the analytes may include, for example: ions, molecules, groups of chemically related substances, substance, family of substances such as proteins and chemical species.
  • Matrix includes all matter that is not measured, for example: cell debris, substances interfering with analyte measurement, analyte complex forming/binding substances that interfere with analyte measurement.
  • Washable means herein a device that can be successively used by cleaning it between consecutive operative steps, opposite to a single use device that is discarded after every contact with analyte or ather liquid in order to avoid contamination.
  • FIG. 1 shows a typical discrete analyzer.
  • these apparatuses have been in laboratory use and their operation principles are known to persons skilled in the art or can be easily studied from operating manuals and basic literature, only a cursory description of the apparatus shown in FIG. 1 is provided herein as an example.
  • the invention is not limited to any specific type of an automated discrete analyzing device as long as its operation is controlled by sample handling rules permitting sample handling routines for each sample so that a request to analyze a sample may include an assay of the measurements required and a request for pretreatment if such is desired.
  • FIG. 1 shows the main elements of an analyzing device. These are arranged on a suitable frame and include diluent water container 1 and waste water container 2 . Samples to be analyzed are placed on sample wheel 4 and reagents, enzymes and other media needed for analyses on reagent wheel 3 . Samples are handled with sample dispenser 5 and reagents with reagent dispenser 6 . Measurements of analytes or components within the samples occur in incubator 7 with a photometer 8 .
  • a pretreatment unit 9 is arranged in relation to sample wheel 4 .
  • the sample wheel 4 is divided in sections that form racks 10 , 11 , 12 arranged as reagent rack 10 for elution and wash liquids, microplate rack 11 for pretreated samples and sample racks 12 for untreated samples.
  • reagent rack 10 for elution and wash liquids
  • microplate rack 11 for pretreated samples
  • sample racks 12 for untreated samples.
  • a cuvette dispenser 13 Between the sample and reagent wheels is a cuvette dispenser 13 .
  • FIG. 1 represents an exemplary arrangement with other arrangements possible.
  • cuvettes are fed from the cuvette dispenser 13 to the incubator 7 whereafter sample volumes of the collected sample are aspirated with the sample dispenser 5 into the cuvettes as requested by analyzing assay request of the sample. Accordingly, reagents needed for requested measurements are dispensed by reagent dispenser 6 into the cuvettes and after a measurement specific incubation period, the measurement is performed for each cuvette by photometer.
  • the analyzing assay request includes pretreatment
  • a portion of the sample is aspirated in the pretreatment unit 9 .
  • a side view of unit 9 is shown in FIG. 2 .
  • the exemplary pretreatment unit of this embodiment is built on a frame 14 that is rotatably mounted on the analyzing device.
  • the main parts of the pretreatment unit may include a pump for sample aspiration and ejection through line 17 .
  • Line 17 connects the pump line to a pretreatment column 16 .
  • the column shown in this embodiment is on a grooved stationary wheel 18 .
  • the column is connected to a suction or pipetting tube 15 for aspiration and ejection of the sample.
  • pretreatment column 16 is a column containing internal surfaces that immobilize the analyte from the sample to the surfaces of the column. These surfaces may be walls of the column itself or some filler material, which may be in particle or fibrous form. For pretreatment in such a column the substance must be first retained and then released from the surfaces and placed into cuvettes in for measurements. For this the sample wheel has a reagent rack 10 for elution and wash liquids. Further, FIG. 1 shows a washing station 19 arranged in vicinity of pretreatment unit 9 . When a pretreatment is needed, the cycle may start with a washing cycle of the column 16 at the washing station 19 , but usually the column 16 is washed at the end of the pretreatment cycle.
  • Washing is performed simply by aspirating water or other washing liquid into the column so that it is substantially filled and then ejecting the washing solution into a waste container 2 .
  • the aspiration and ejection is repeated as many time as needed to obtain desired level of purity and the washing liquid may be pumped reciprocatingly in order to increase removing effect.
  • a desired amount of sample liquid is aspirated into the column 16 through pipetting line 15 and the sample is pumped through the column so that at least the entire sample volume has entered the column.
  • the substance for example a molecule
  • the sample may be kept in the column or pumped reciprocatingly in the column to ensure sufficient reaction time. Heating or cooling of the sub-sample may be used for enhanced effect. After the reaction time needed to immobilize the target analyte has passed, the sample is ejected from the column.
  • the target analyte remains immobilized within the column.
  • the immobilized molecule or substance must be eluted from the surface via washing the column with an elution liquid placed in the reagent rack 10 .
  • the elution liquid is ejected together with the substance eluted from the column 16 to a microplate rack 11 to await transfer to the incubator or directly to the cuvette in the incubator.
  • the measurement of the sample occurs in a routine manner, for example, by a photometer according to operating principles of the analyzing apparatus.
  • the pretreatment step is merely one additional handling step in the analyzer for the sample and can be arranged within the normal measuring cycle without disturbing the operation of the apparatus or changing the function, construction or operation of the apparatus.
  • the pretreatment unit and washing stations, reagents and elution liquids may be fitted to existing apparatuses without difficulty.
  • the main problem with handling samples for discrete analyzers is the small volume of the sample. Since the volume of the sample is small, many traditional pretreatment methods like evaporation or treatments based on chemical reactions performed on the substance to be measured are difficult to implement.
  • the present invention provides a solution to this problem by using capture or immobilization methods for either enriching the substance that is measured or its proportion in the sample. This is accomplished by retaining the target analyte or retaining other substances that interfere with the measurement of the target analyte and removing them from the sample.
  • the retaining method itself may vary, but the immobilization method discussed above provides one embodiment suitable for implementation for many various measurements.
  • binding may occur through covalent bonds, electrostatic interactions or van der Waals forces or other surface forces between molecules or substances.
  • This method of using a pretreatment unit enables transfer of the treated sample into the measurement unit. Transfer is controlled by a user friendly software whereby the instrument user may simply add the primary sample tube in the instrument sample feeding unit and program the desired assay. When a sample pretreatment step is necessary, the software automatically directs the sample into the pretreatment unit, while other analyses from the same sample or other samples continue to be performed without delay or disturbance.
  • the present invention benefits numerous assays.
  • many physiologically important compounds including without limitation, Vitamin A, D and E, are fatsoluble and/or bound in circulation to a corresponding binding protein or other protein structures.
  • Serum vitamin D samples must be pretreated in order to disrupt the protein complex and extract the analyte in an organic solvent such as acetonitrile or methanol by a manual procedure.
  • an organic solvent such as acetonitrile or methanol
  • the analyte can be eluted by a suitable solvent and then transferred to the assay performing unit. Immobilisation may be accomplished by antibody binding or by chemical binding and the surface will be automatically regenerated and washed between samples.
  • a similar separation step may be adapted to many small molecular compounds and thus avoid using instrumentation more complicated than a photometer.
  • the pretreatment surface may comprise a coated surface inside a glass or metallic column, enabling solid phase extraction. Particles of uniform or different size may be coated and packed in a tube or other column container. Coated fibers or other materials may also be used.
  • the reactive surface may also comprise a microfluistic platform or otherwise comprise liquid pathways molded or printed on various suitable materials.
  • the coating may include anti-bodies or other specific binders. Also, many chemically reactive surfaces (hydrophilic, hydrophobic, lipophilic, nitrogenous or organic group binding) may be useful. In one embodiment, binding is irreversible or accomplished via bonds from which the substance can be removed and the surface regenerated or comprises equilibrium binding.
  • the pretreatment unit may comprise a surface coated with an antibody against the analyte which is measured by a standard photometric method.
  • pretreatment may be used to purify the sample by immoblizing a cross-reacting substance using an antibody against the substance that is coated on the pretreatment surface.
  • the purified sample can then be measured by standard turbidimetry or other methods.
  • antibodies may cross-react with substances related to the desired analyte. Pretreatment to remove such cross-reactants may avoid such problems and antibodies or other binding or marker substances with lower specificity may be used. Such an approach may lead to reductions of the costs of antibody development.
  • TSH thyrotrophin-stimulating hormone
  • iso-alpha-acids are monitored during the brewing process to estimate bitterness of beer.
  • the reference method used employs extraction with iso-octane. This procedure may be omitted and the assay automated by using pretreatment where the target iso-alpha-acids are bound to a surface and then eluted by a suitable solvent, to be transferred to measurement unit.
  • DoA drugs of abuse
  • One aspect of the invention is to enrich, purify or fractionate one or more analytes to be measured from a sample by retaining methods like immobilization, sieving or filtering.
  • Immobilization may be done on surfaces or by anti-bodies so that desired substances or matrix components are retained.
  • Filtering for example by membranes, may be used to separate and retain molecules of desired size.
  • Cell separation can be performed by flow-through microchannels.
  • Pretreatment may be divided or arranged in two separate phases including pretreatments such as: reagent addition+incubation to form complex, reagent addition+incubation with proteolytic or other enzymes to be removed later, removal of lipids (lipemia) and removal of hemoglobin or other interfering substances.
  • the substance or substances that are to be measured are not chemically or physically reacted, modified or altered so, that the information content of a small sample used in discrete analysis is maintained as unchanged as possible.
  • the invention is based on picking desired substances from the sample in order to enrich the sample itself or, preferably the analyte to be measured directly.
  • Different substance may require different pretreatment means, but the apparatus may be designed so that the pretreatment means such as columns can be easily changed according to assaying needs.
  • the columns or other means may be disposable or reusable, and changed automatically.
  • a sub-sample is removed from the primary sample and the pretreatment is done on the subsample, leaving the primary sample unchanged.
  • the primary sample may be used for further analyses of other substances.
  • One aspect of the invention is to combine above described pretreatment methods with a discrete analysis apparatus.
  • pretreatment step operates integrated with the analyzer so that pretreatment can be performed only when the analyzer receives such a test request that includes a pretreatment step.
  • the pretreatment step operates independently from the analyzer so that normal analyzing processes can be done simultaneously with the pretreatment.
  • the analyzer performs requested measurements for each sample or subsample (sample aliquot) regardless whether the sample/subsample has been pretreated or not. Also, some of the subsamples of one sample analyte may be pretreated and some not, exactly as required. As the pretreatment step does not interfere with the measurements performed by the analyzer, several measurement cycles may occur simultaneously in the analyzer.
  • the invention utilizes a discrete fluid analyzing apparatus, wherein measurements are done photometrically or electrochemically on samples placed in separate wells. Reactants are used as needed to induce changes in the analyte in order to obtain response that can be measured photometrically or electrochemically.
  • This type of measurement system is relatively inexpensive. Therefore inexpensive ways to handle the analyte samples and subsamples are preferably used. For example, washable dispensers are used instead of disposable ones. This limits the invention to measurements wherein contamination, cross-contamination or mixing of samples can be avoided to a level that does not interfere with the measurements by washing and cleaning the dispensers or other fluid transfer means, such as dispensing needles, probes or washable pipette tips.
  • the sample or a subsample taken from it undergoes changes during measurement step when reactants are used. Therefore the molecule (analyte) to be measured must not change chemically under the pretreatment step. This is a requirement for the pretreatment step to operate properly with a discrete analyzer.
  • FIG. 3 shows an example of some workflows that can be accomplished by the invention.
  • a sample 1 is obtained.
  • the sample may be any liquid sample, for example beer, wort, blood or urine.
  • the sample is identified by a data carrier such as a RFID chip or bar code and when the sample vessel enters the analyzer, data is read, or the sample can be identified to the system manually by the user, the sample is identified and the operating system of the analyzer requests all pretreatments and measurements that are to be performed on the sample.
  • the sample may be placed on queue or taken directly forwards. Now the whole sample or more commonly one or more subsamples are taken from the sample by a metallic needleand the extracted liquid is placed on measurement wells, such as cuvettes.
  • pretreatment includes capturing and releasing molecule that is to be measured in order to purify or enrich it. See description of pretreatment process for further details. Pretreatment should not change the chemical composition of the analyte.
  • the pretreated sample is transferred to a measurement step. Some examples are shown in FIG. 3 .
  • the sample herein a whole sample, alternatively a subsample
  • pretreatment is part of the Application and is automatically generated by requesting the Application 1 .
  • this application consists of pretreatment step with flexibility to design pretreatment parameters and the actual measurement step. In this case measurement is performed with no reagent additions.
  • Application 1 (ref **) can be for example beer/wort bitterness or polyphenol analysis.
  • Applications 2 and 3 include dispensing at least sample aliquot (subsample), dispensing reagent, incubation and photometric analysis.
  • two or more reagents are used (reagents 2 , 3 , 4 , and 5 ).
  • sample or sample aliquot can be processed according to Applications 4 - 7 .
  • the sample/subsample (aliquot) is measured photometrically without reacting with a reagent (Application 4 ), measured electrochemically without adding reagent (Application 5 ) or by similar methods as in Applications 2 and 3 (Applications 6 and 7 ).
  • the Applications shown here are examples only and any measurement process application available in analyzer may be used in conjuction with both pretreatment steps, i.e. together with actual pretreatment or directing the sample or subsample directly to measurement step.
  • Applications 2 - 7 can be for example Beta-Glucan, Glucose, pH, conductivity, hemoglobin, HbAlC analysis, Ammonia or sulphate measurements.
  • Sample dispensing does not require disposable tips. Vice versa, disposable tips should be avoided in order to keep the operating costs at bay.
  • Application examples can have flexibility for volumes, dispensing orders and includece e.g additional sample blankings.
  • FIG. 4 shows one operating principle of the invention using an explanatory display template.
  • the process starts when client requests a test.
  • This request can be delivered to the analyzer by a memory device or made manually when a sample is loaded to the analyzer.
  • the analyzer automatically selects a pretreatment step including pretreatment or no pretreatment according to the specifications of the test as well as measurements, reagents, incubation time, mixing and other features. All parameters may be determined flexibly.
  • the left side of the display shows a list of test and treatments available.
  • a test Bitter 300 is requested (highlighted).
  • the list shows that the test is photometric and pretreatment is on use.
  • On the right side is information about the test which shows that pretreatment method is Bitter AU. Further details about reagents, samples, incubation and such used in a particular test are placed under tabs with same nominations (now shown in this display). The flow of the test is displayed on the right side of the tabs.
  • Bitter 300 request performs automatically a Bitter AU pretreatment (selection: Pretreatment procedure: Bitter AU) and thereafter a photometric test typical to a discrete analyzer.
  • selection Pretreatment procedure: Bitter AU
  • photometric test typical to a discrete analyzer.
  • the parameters of the photometric test are placed under the tabs bearing nominations of the parameters.
  • the analyzer is capable of performing multiple different tests (see test name) simultaneously and some of the tests may include pretreatment and some not.
  • a pretreatment step can also be performed without a following photometric test requiring additional reagents. Usually a subsample of the original or pretreated sample is needed for each test.
  • Various embodiments of the method according to the invention are capable of performing optional, on demand pretreatment, simultaneous measurement and pretreatment, and/or measurement.
  • Pretreatment may be performed on a whole sample r subsample or sample aliquot of the whole sample. Several tests may be performed on a single sample. Sample or sample aliquot can also be automatically treated or e.g. adjusted for pH by reagent addition before pretreatment.

Abstract

A method and apparatus for pretreatment of a desired sample in a discrete fluid analyzing instrument comprises automated means for handling and analyzing the sample and means for performing a pretreatment step on the sample or a sub-sample of the sample. The means for pretreatment are used for immobilizing at least one substance or analyte from the sample or sub-sample wherein the substance or analyte is reversibly immobilized. Usually, the apparatus further comprises means for eluting the substance or analyte from the capture means prior to analysis.

Description

  • The present invention relates to method and apparatus for automated sample treatment for automated discrete fluid analyzer
    • BACKGROUND OF THE INVENTION
  • Several chemical analyses are done by automatic analyzing equipment in hospitals and laboratories. The level of automation varies, but present trend is to streamline the analyzing work as much as possible. As many more complicated analyses must be performed manually by highly trained laboratory personnel, the productivity and throughput of such laboratory testing services has been low. By increasing the automation capabilities of the laboratory, more of the work can be performed inside the automatic systems without involvement of highly skilled personnel. Ideally laboratory assistants simply load samples in racks into the analyzing apparatuses freeing laboratory chemists and biologists to focus on interpretating the results and managing the operation of the laboratory. Such a system provides good throughput combined with high certainty and quality of analytical results.
  • Automated instruments for various kind of chemical analysis have been widely used for decades. They may combine both routine and sophisticated assay techniques such as spectrophotometry, fluorometry, time resolved fluorometry, chromatographic methods etc. with automated sample dispensing from original sample containers. Automation is often required as test workload increases within healthcare and clinical laboratories, public or commercial research and service institutes, or industrial process control.
  • Automatic discrete analysis techniques use computer controlled automation to perform steps similar to those of manual methods. For example, a computer controlled robotic arm may be used to position a probe of a pipettor to aspirate or deposit a fluid sample, buffer or reagent into or out of any of a plurality of sample receptacles, a plurality of reagent receptacles and a plurality of reaction cuvettes. This is a “discrete” analysis technique because each sample is deposited in a discrete reaction cuvette, which is then subjected to an assaying device such as colorimetric photometer, or the like. Typically several discrete analyses may be done on subsamples divided from a main sample placed on a receptacle. For example, from a serum sample, a panel of serum lipids (triglyserides, cholesterol and HDL-cholesterol) can be measured.
  • Many sample types, particularly human samples for clinical testing, are not ready for assay as collected and, instead, require a pretreatment step. For example, plasma or serum must be separated from whole blood; whole blood must be hemolyzed to release intracellular components; fecal, sputum or solid tissue samples must be homogenized and suspended in liquids. In many cases of human excretions or other biological and industrial materials, interfering proteins must be precipitated, or analytes extracted from the original sample matrix. So while automatic analyzers have significantly improved throughput rate of analytical testing service, manual sample pretreatment has become a primary bottleneck in daily work flow.
  • Manual processes not only add to the time and labor required to produce results but also increase the risk of errors. Errors during the analytical process have been addressed primarily by automation as automation standardizes pipetting and dispensing steps, and eliminates variation in timing and differences between individual technicians. Sample pretreatment, however, remains prone to problems and would benefit from automation as well.
  • To increase sample throughput and provide process standardization, some automated or semi-automated sample pretreatment instruments have been developed. These are mainly meant to be used in connection with highly sophisticated analysis techniques that require sample purification steps before the actual measurement can be performed. For example, TurboFlow™ columns (Thermo Fisher Scientific) are used to separate small molecules from proteins or other large molecules in a sample before introduction to a LC/MS system. For PCR techniques, desired cell types must often be selected from complex sample mixtures for further treatment, and sample DNA or RNA must be purified to substantially eliminate background contamination before the actual cycling process. Semi-automated pretreatment instruments like those based on magnetic particles, eg. the KingFisher™ instrument (Thermo Fisher Scientific), are useful for such processes.
  • Publications Wo 2004096443, US 2005069913, U.S. Pat. No. 5,985,153 and U.S. Pat. No. 7,897,337 disclose examples of automated pretreatment methods and apparatuses and fully automated analyzing processes including pretreatment of all input samples. These are mainly used for DNA and RNA analysis wherein pretreatment is needed for all samples before analysis can be performed. Contamination risk is also extremely high. Usually disposable sample containers are needed, as well as disposable pipette tips or dispensers for transporting samples, sample aliquots, analytes and reagents.
  • However, many laboratories must function without such sophisticated automated or semi-automated equipment. Typically, the main daily workload of many clinical laboratories is performed using low-cost automated analyzers based on simple analytical techniques such as photometry or spectrophotometry. Such analyzers usually employ conventional assay methods that provide result levels traditionally considered sufficient for measurement of clinically significant ranges. Many compromises concerning acquired information and accuracy are made in order to achieve acceptable cost and speed while providing ease of use and maintenance.
  • Sample pretreatment is often considered as a separate process from the actual assay and, therefore, not well suited to instruments streamlined to perform one type of analytical process or measurement quickly and efficiently. Pretreatments are designed according to sample matrix and nature of analyte, and are usually not bound to particular assay principles. This may explain the lack of pretreatment automation, as sample oriented additional steps preceeding the chemical assay reaction would lower throughput and cause difficulty in timing of assay sequences.
  • Despite difficulties in combining pretreatment processes with automatic discrete analysis, some pretreatment systems have been combined to automatic analysis apparatuses. Some of these systems are described below for reference.
    • On-Board Pretreatment of Whole Blood in Discrete Photometric Analyzers in the Measurement of Glycated Hemoglobin Alc (HbAlc).
  • In on-board methods to measure HbAlc, a sample of whole blood is hemolyzed within a discrete photometric analyzer to release the hemoglobin molecules from within blood cells. Hemolyzation is carried out by mixing whole blood with hemolyzing reagent in a reaction vessel or a cuvette and incubating the mixture for a defined time. After hemolyzation, an aliquot of the mixture is sampled to measure HbAlc content with a turbidimetric inhibition immunoassay and another aliquot is sampled to measure total hemoglobin content. In such method, the analytes and matrix components are not separated prior to the analyzing. This kind of analysis can be performed by Konelab™ clinical chemistry analyzers (Thermo Fisher Scientific), for example.
    • Cadmium Column Reduction of Nitrate
  • In a cadmium column, nitrate (NO3-) is reduced to nitrite (NO2-) using Cd2+ granules as catalyst. The reduction is accomplished by aspirating sample to the column where the reduction takes place and then eluting the reduced sample to a vessel. From the vessel an aliquot is sampled to measure nitrite. This kind of analysis can be performed by an Aquakem™ analyzer (Thermo Fisher Scientific). In this system analytes undergo a chemical reaction during the pretreatment; there is no means for separating reacted from unreacted or other non-target analytes. The nitrate reduction to nitrite can also be performed in a reaction vessel. US 2009/0162942 discloses an automated discrete fluid sample analyzer that includes a sample preparation module. The sample preparation module includes a well configured to receive a sample deposited by a pipettor and a sample preparation device in fluid communication with the well. The fluid sample is transferred from the well to the sample preparation device which prepares the sample by using catalyst, ultraviolet light or heat. The target analyte is not separated from the sample.
    • SUMMARY OF THE INVENTION
  • The present invention provides a novel approach to arrange integrated pretreatment for automated discrete analyzing apparatus.
  • According to one preferred embodiment of the invention, an integrated pretreatment step is provided comprising selectively either a pretreatment wherein at least one matrix substance is retained from a sample volume without chemically changing the chemical composition of the analyte or the sample is left untreated, whereafter one or more analysis are performed on the sample.
  • According to one ambodiment of the invention, the measurements are performed with a discrete fluid analyzer that performs chemical reactions and photometric measurements in single/separate wells.
  • According to one embodiment of the invention, the measurement is at least one of the group comprising photometric measurement or electrochemical measurement.
  • According to one especially preferred embodiment, at least two different measurements are performed on subsamples of one sample; either after a pretreatment is performed, without performing the pretreatment or both.
  • According to one embodiment of the invention, dispensing and transportation of subsamples of an analyte sample volume is performed with anon-disposable or an on board washable dispenser or dispenser tip.
  • According to one embodiment of the invention, at least one measurement is performed on pretreated or not pretreated subsample (sample aliquot) without reacting the subsample chemically.
  • According to one embodiment of the invention, at least one measurement is performed on pretreated or not pretreated subsample (sample aliquot) after adding at least one reagent thereto.
  • According to one preferred embodiment of the invention at least one matrix substance or analyte is retained from the sample volume by capture means wherefrom it is reversibly removable.
  • According to one preferred embodiment, the matrix substance or analyte that is retained, is eluted or regenerated from the capture means for measurement.
  • According to one preferred embodiment, analyte is retained.
  • According to one embodiment of the invention, the analyte is retained by a method that is chemically inactive in relation to the analyte that is measured from the pretreated volume.
  • According to another aspects and embodiments of the present invention, the invention provides a method wherein the analyte to be measured is retained by immobilization.
  • According to one specific feature of the invention, the invention utilizes a surface that immobilizes the substance that is to be measured.
  • At least one embodiment of the invention enables to enrich analytes. Enrichment is needed when the concentration of analytes in the sample is too low for the measurement. This can be done by retaining the analytes in, for example a column, or other suitable apparatus, and eluting them in a volume that is smaller than the initial volume.
  • At least one embodiment of the invention enables the separation of analytes and matrix components that interfere with the analyte measurement. This is done either by retaining the analytes in a column or other suitable apparatus, and washing matrix components out before analyte elution, or by retaining the matrix components in the column and washing the analytes out before matrix elution.
  • The above mentioned embodiments may be used at least for:
      • separating analytes from complex forming or binding molecules,
      • separating analytes from cell debris,
      • separating analytes from substances interfering with analyte detection,
      • desalting the sample,
      • exchanging the sample solvent,
      • separating analytes from matrix substances.
  • At least one embodiment of the invention is applicable to fractionation of analytes into different fractions. This is done by retaining the analytes in the column or on other substrates, and eluting the analytes in fractions by using eluents with increasing elution strength.
  • Isolation and/or concentration of analytes from a sample can be achieved by using one of the following methods, or any combination of two or more, including but not limited to:
      • immobilization/retention by use of:
      • 1) antibodies or other specific binding substances,
      • 2) passive adsorption,
      • 3) covalently binding substances, or by filtering
      • concentration via immobilization and elution into reduced volume,
      • immobilization of a non-target substance from the sample to increase assay specificity,
      • immobilization of a substance from the sample to avoid interference with assay performance,
      • partial purification of a sample by immobilization and elution of a substance from a complex forming mixture of substances,
      • separation of a target analyte from cell debris,
      • separation of an analyte from complex forming or binding molecules,
      • separation or purification of derivatives of the analyte.
  • The modes by which the retention is accomplished include, but is not limited to, reversible covalent bonding, ionic interaction, sieving or filtering (molecular size and shape, diffusion), polarity, hydrophobicity, molecule or group specific interaction and chiral recognition.
  • The invention, in one aspect, is an automated discrete fluid analyzing device providing sample pretreatment wherein at least one substance of the sample matrix or analyte is retained.
  • In another aspect the invention is an automated discrete photometric analyzing device providing sample pretreatment wherein at least one substance of the sample matrix or analyte is retained.
  • According to one embodiment, at least one substance is retained by immobilizing it to a solid support and eluting it from the solid support for analysis and/or measurement.
  • According to one embodiment the retained substance is removed from the sample and not subjected to analysis.
  • According to one embodiment of the invention at least one substance is retained from the sample by a filtration method, such as membrane filtration or a gel filtration.
  • According to one embodiment of the invention, the at least one substance is retained by immobilization on a solid support.
  • According to one embodiment of the invention, the at least one substance is retained by immobilization by an antibody.
  • According to one or more embodiments of the invention, the at least one substance is retained by one or more of following methods: reversible covalent bonding, ionic interaction, sieving or filtering (molecular size and shape, diffusion), polarity, hydrophobicity, molecule or group specific interaction and chiral recognition.
  • Examples of Sample pretreatment process
    Sample contains Analyte(s) of interest (A), Interfering (I) and
    Other substances (O) and water or other Fluid (F).
    In this invention, upon user request by software, subsample is taken
    and automatically pretreated to bring the unaltered analyte of interest
    (A) to the discrete photometric analysis.
    Component(s)
    Component(s) removed
    retained from the
    in the pretreat
    pretreatment treatment Samples for the discrete photometric
    No Sample unit unit analysis
    1 A + F + I + O A (Analyte) I + F + O Analyte is concentrated and/or
    purified in the pretreatment phase.
    In the measurement phase analyzer
    can automatically calculate its
    original concentration in the sample.
    Analyte remains intact
    throughout the process.
    2 A + F + I + O I (Interfering A + F + O Sample is pretreated to clean the
    substance) interfering substances. Interfering
    substance(s) (I) are retained in
    the pretreatment unit. Unaltered
    analyte is transferred eg. into a
    secondary sample holder and further
    directed to analysis. Thereafter
    the capturing device is regenerated
    and elution and regeneration liquids
    are descarded. Analyte of interest
    (A) can be calculated to the original
    concentration in the sample
    after the discrete photometer measurement
    for the specific analyte.
    3 A + F + I + O Sample is Sample can also be analyzed as such
    not without the pretreatment step
    directed
    to the
    pretreatment
    unit
    4 A + F + I + O Two or more pretreatments in any order
  • Other objects and features of the invention will become apparent from the following detailed description considered in conjunction with the accompanying drawings. It is to be understood, however, that the drawings are intended solely for purposes of illustration and not as a definition of the limits of the invention, for which reference should be made to the appended claims.
    • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows diagrammatically an automated discrete fluid analyzing device to which the invention is implemented.
  • FIG. 2 shows diagrammatically one embodiment of a pretreatment unit for device in FIG. 1.
  • FIG. 3 shows a flow diagram of one operation workflow of the invention.
  • FIG. 4 shows an explanatory screen display of an apparatus utilizing the invention.
    •  DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED EMBODIMENTS
  • In the subsequent text the following terms and devices should be understood to be defined as below:
    • Pretreatment
  • Separate step from analysis chemistry; provides eg. a concentrated, fractionated or purified analyte. In general pretreatment may be modifying or non-modifying in relation to the substance to be pretreated.
    • Discrete Fluid Analyzer
  • Discrete fluid analyzer performs chemical reactions and photometric measurements in single/separate wells. Usually an analyzer contains multiple wells in which different reactions are ongoing simultaneously. Several different tests may be requested from each sample. Also different types of samples may be analyzed simultaneously.
    • Column
  • Column is typically a cylindrical or other formed vessel to which liquid samples and reagents may be introduced and analytes and/or other components eluted. The column may be in-line connected to a pump or syringe in which case the samples and reagents are pumped to and from the column using positive or negative pressure. Or the column may be freely diffusing in which case samples and reagents are drawn to and from the column by gravity or by centrifugal force. The column may be packed or lined with material that has affinity towards the analytes or matrix components. As an alternative, the column may be packed with material that functions as a sieve or filter. Physical treatments may also be connected to the column.
  • The column may be single use (disposable) or reusable.
    • Sample
  • A whole sample as collected is a “sample” or “primary sample”. The part of the sample that is pretreated, is a “sub sample”.
  • The substances that are analyzed are analytes. All other components in a sample are matrix.
  • The analytes may include, for example: ions, molecules, groups of chemically related substances, substance, family of substances such as proteins and chemical species.
  • Matrix includes all matter that is not measured, for example: cell debris, substances interfering with analyte measurement, analyte complex forming/binding substances that interfere with analyte measurement.
    • Washable
  • Washable means herein a device that can be successively used by cleaning it between consecutive operative steps, opposite to a single use device that is discarded after every contact with analyte or ather liquid in order to avoid contamination.
  • FIG. 1 shows a typical discrete analyzer. As these apparatuses have been in laboratory use and their operation principles are known to persons skilled in the art or can be easily studied from operating manuals and basic literature, only a cursory description of the apparatus shown in FIG. 1 is provided herein as an example. The invention is not limited to any specific type of an automated discrete analyzing device as long as its operation is controlled by sample handling rules permitting sample handling routines for each sample so that a request to analyze a sample may include an assay of the measurements required and a request for pretreatment if such is desired.
  • FIG. 1 shows the main elements of an analyzing device. These are arranged on a suitable frame and include diluent water container 1 and waste water container 2. Samples to be analyzed are placed on sample wheel 4 and reagents, enzymes and other media needed for analyses on reagent wheel 3. Samples are handled with sample dispenser 5 and reagents with reagent dispenser 6. Measurements of analytes or components within the samples occur in incubator 7 with a photometer 8.
  • For the pretreatment of a sample, a pretreatment unit 9 is arranged in relation to sample wheel 4. The sample wheel 4 is divided in sections that form racks 10, 11, 12 arranged as reagent rack 10 for elution and wash liquids, microplate rack 11 for pretreated samples and sample racks 12 for untreated samples. Between the sample and reagent wheels is a cuvette dispenser 13. FIG. 1 represents an exemplary arrangement with other arrangements possible.
  • In further description of FIG. 1, when pretreatment is not needed for the indicated measurement, cuvettes are fed from the cuvette dispenser 13 to the incubator 7 whereafter sample volumes of the collected sample are aspirated with the sample dispenser 5 into the cuvettes as requested by analyzing assay request of the sample. Accordingly, reagents needed for requested measurements are dispensed by reagent dispenser 6 into the cuvettes and after a measurement specific incubation period, the measurement is performed for each cuvette by photometer.
  • When the analyzing assay request includes pretreatment, a portion of the sample is aspirated in the pretreatment unit 9. A side view of unit 9 is shown in FIG. 2.
  • The exemplary pretreatment unit of this embodiment is built on a frame 14 that is rotatably mounted on the analyzing device. The main parts of the pretreatment unit may include a pump for sample aspiration and ejection through line 17. Line 17 connects the pump line to a pretreatment column 16. In order to enable use of a long column 16 and sufficient pretreatment time and to keep the dimensions of the pretreatment unit 9 small, the column shown in this embodiment is on a grooved stationary wheel 18. On the opposite end of the pump 17, the column is connected to a suction or pipetting tube 15 for aspiration and ejection of the sample.
  • One type of pretreatment column 16 is a column containing internal surfaces that immobilize the analyte from the sample to the surfaces of the column. These surfaces may be walls of the column itself or some filler material, which may be in particle or fibrous form. For pretreatment in such a column the substance must be first retained and then released from the surfaces and placed into cuvettes in for measurements. For this the sample wheel has a reagent rack 10 for elution and wash liquids. Further, FIG. 1 shows a washing station 19 arranged in vicinity of pretreatment unit 9. When a pretreatment is needed, the cycle may start with a washing cycle of the column 16 at the washing station 19, but usually the column 16 is washed at the end of the pretreatment cycle. Washing is performed simply by aspirating water or other washing liquid into the column so that it is substantially filled and then ejecting the washing solution into a waste container 2. The aspiration and ejection is repeated as many time as needed to obtain desired level of purity and the washing liquid may be pumped reciprocatingly in order to increase removing effect.
  • For pretreatment a desired amount of sample liquid is aspirated into the column 16 through pipetting line 15 and the sample is pumped through the column so that at least the entire sample volume has entered the column. This forms a sub-sample of the original sample, which remains untreated and may be used for other measurements without the effects of pretreatment. In the column, the substance, for example a molecule, is retained and immobilized on the wall or other interior surface of the column. For this, the sample may be kept in the column or pumped reciprocatingly in the column to ensure sufficient reaction time. Heating or cooling of the sub-sample may be used for enhanced effect. After the reaction time needed to immobilize the target analyte has passed, the sample is ejected from the column. The target analyte remains immobilized within the column. In order to make the measurement, the immobilized molecule or substance must be eluted from the surface via washing the column with an elution liquid placed in the reagent rack 10. The elution liquid is ejected together with the substance eluted from the column 16 to a microplate rack 11 to await transfer to the incubator or directly to the cuvette in the incubator. The measurement of the sample occurs in a routine manner, for example, by a photometer according to operating principles of the analyzing apparatus. Thus, the pretreatment step is merely one additional handling step in the analyzer for the sample and can be arranged within the normal measuring cycle without disturbing the operation of the apparatus or changing the function, construction or operation of the apparatus. The pretreatment unit and washing stations, reagents and elution liquids may be fitted to existing apparatuses without difficulty.
  • The main problem with handling samples for discrete analyzers is the small volume of the sample. Since the volume of the sample is small, many traditional pretreatment methods like evaporation or treatments based on chemical reactions performed on the substance to be measured are difficult to implement. The present invention provides a solution to this problem by using capture or immobilization methods for either enriching the substance that is measured or its proportion in the sample. This is accomplished by retaining the target analyte or retaining other substances that interfere with the measurement of the target analyte and removing them from the sample. The retaining method itself may vary, but the immobilization method discussed above provides one embodiment suitable for implementation for many various measurements.
  • Another approach to retaining a substance is adsorption or physical bonding of the substance to a surface or another substance via chemical binding. In practice binding may occur through covalent bonds, electrostatic interactions or van der Waals forces or other surface forces between molecules or substances.
  • Various pretreatment methods will be discussed below in further detail.
  • This method of using a pretreatment unit enables transfer of the treated sample into the measurement unit. Transfer is controlled by a user friendly software whereby the instrument user may simply add the primary sample tube in the instrument sample feeding unit and program the desired assay. When a sample pretreatment step is necessary, the software automatically directs the sample into the pretreatment unit, while other analyses from the same sample or other samples continue to be performed without delay or disturbance.
  • Within the clinical and non-clinical fields, the present invention benefits numerous assays.
  • For example, many physiologically important compounds including without limitation, Vitamin A, D and E, are fatsoluble and/or bound in circulation to a corresponding binding protein or other protein structures. Serum vitamin D samples must be pretreated in order to disrupt the protein complex and extract the analyte in an organic solvent such as acetonitrile or methanol by a manual procedure. With a pretreatment unit containing a surface for immobilizing the formed complex, the analyte can be eluted by a suitable solvent and then transferred to the assay performing unit. Immobilisation may be accomplished by antibody binding or by chemical binding and the surface will be automatically regenerated and washed between samples. A similar separation step may be adapted to many small molecular compounds and thus avoid using instrumentation more complicated than a photometer.
  • The pretreatment surface may comprise a coated surface inside a glass or metallic column, enabling solid phase extraction. Particles of uniform or different size may be coated and packed in a tube or other column container. Coated fibers or other materials may also be used. The reactive surface may also comprise a microfluistic platform or otherwise comprise liquid pathways molded or printed on various suitable materials. The coating may include anti-bodies or other specific binders. Also, many chemically reactive surfaces (hydrophilic, hydrophobic, lipophilic, nitrogenous or organic group binding) may be useful. In one embodiment, binding is irreversible or accomplished via bonds from which the substance can be removed and the surface regenerated or comprises equilibrium binding.
  • Sophisticated and time consuming chromatographic techniques are often used to measure components in mixtures, if there are no simple ways to separate the required analyte from the other constituents. In these cases, the pretreatment unit may comprise a surface coated with an antibody against the analyte which is measured by a standard photometric method.
  • On the other hand, pretreatment may be used to purify the sample by immoblizing a cross-reacting substance using an antibody against the substance that is coated on the pretreatment surface. The purified sample can then be measured by standard turbidimetry or other methods.
  • Within some immunoassays antibodies may cross-react with substances related to the desired analyte. Pretreatment to remove such cross-reactants may avoid such problems and antibodies or other binding or marker substances with lower specificity may be used. Such an approach may lead to reductions of the costs of antibody development.
  • An important application of the invention are assays that today cannot be performed by photometric methods because of their low sensitivity. For instance, the preferred hormone to diagnose thyroid disorders, thyrotrophin-stimulating hormone (TSH), is typically so low in serum concentration that complicated techniques usually performed by separate instruments are used for measurements of TSH. If, however, an immunoaffinity pretreatment method for TSH is used to concentrate TSH approximately 10-fold or more, a useful turbidimetric assay is possible.
  • For food safety, analysis of various toxic mycotoxins in agricultural products is very important. For concentration and separation from sample matrices, extractions and immunoaffinity steps are necessary prior to assay. These steps may be automated by using specific antibodies or mycotoxin group binders for solid phase extraction in the pretreatment unit.
  • A similar approach is useful in environmental analysis when measuring cyanotoxins, produced by Cyanobacteria.
  • In the brewery industry, certain iso-alpha-acids are monitored during the brewing process to estimate bitterness of beer. The reference method used employs extraction with iso-octane. This procedure may be omitted and the assay automated by using pretreatment where the target iso-alpha-acids are bound to a surface and then eluted by a suitable solvent, to be transferred to measurement unit.
  • Many drugs of abuse (DoA) are tested in urine samples. This testing is frequently hampered by analyte related molecules or drug metabolites that cross-react with the employed antibodies, causing false positive results. With a suitable pretreatment the interfering molecules can be removed and a reliable assay performed thereafter.
  • On the other hand, many DoA assay suffer from lack of sensitivity which may lead to false negative results. Here, the urine sample can be directed into a column where drug molecules are retained, and then eluted with a smaller volume than the original samples. Thus better sensitivity and higher reliability is achieved.
  • One aspect of the invention is to enrich, purify or fractionate one or more analytes to be measured from a sample by retaining methods like immobilization, sieving or filtering. Immobilization may be done on surfaces or by anti-bodies so that desired substances or matrix components are retained. Filtering, for example by membranes, may be used to separate and retain molecules of desired size. Cell separation can be performed by flow-through microchannels. Pretreatment may be divided or arranged in two separate phases including pretreatments such as: reagent addition+incubation to form complex, reagent addition+incubation with proteolytic or other enzymes to be removed later, removal of lipids (lipemia) and removal of hemoglobin or other interfering substances. In one embodiment, the substance or substances that are to be measured are not chemically or physically reacted, modified or altered so, that the information content of a small sample used in discrete analysis is maintained as unchanged as possible. Alternatively the invention is based on picking desired substances from the sample in order to enrich the sample itself or, preferably the analyte to be measured directly. Different substance may require different pretreatment means, but the apparatus may be designed so that the pretreatment means such as columns can be easily changed according to assaying needs. The columns or other means may be disposable or reusable, and changed automatically.
  • In a discrete analysis several measurements may be done from a single sample. To accomplish this using the present invention, a sub-sample is removed from the primary sample and the pretreatment is done on the subsample, leaving the primary sample unchanged. Thus, the primary sample may be used for further analyses of other substances.
  • One aspect of the invention is to combine above described pretreatment methods with a discrete analysis apparatus. The idea is that pretreatment step operates integrated with the analyzer so that pretreatment can be performed only when the analyzer receives such a test request that includes a pretreatment step. The pretreatment step operates independently from the analyzer so that normal analyzing processes can be done simultaneously with the pretreatment. The analyzer performs requested measurements for each sample or subsample (sample aliquot) regardless whether the sample/subsample has been pretreated or not. Also, some of the subsamples of one sample analyte may be pretreated and some not, exactly as required. As the pretreatment step does not interfere with the measurements performed by the analyzer, several measurement cycles may occur simultaneously in the analyzer.
  • According to one valuable aspect of the invention, the invention utilizes a discrete fluid analyzing apparatus, wherein measurements are done photometrically or electrochemically on samples placed in separate wells. Reactants are used as needed to induce changes in the analyte in order to obtain response that can be measured photometrically or electrochemically. This type of measurement system is relatively inexpensive. Therefore inexpensive ways to handle the analyte samples and subsamples are preferably used. For example, washable dispensers are used instead of disposable ones. This limits the invention to measurements wherein contamination, cross-contamination or mixing of samples can be avoided to a level that does not interfere with the measurements by washing and cleaning the dispensers or other fluid transfer means, such as dispensing needles, probes or washable pipette tips.
  • The sample or a subsample taken from it undergoes changes during measurement step when reactants are used. Therefore the molecule (analyte) to be measured must not change chemically under the pretreatment step. This is a requirement for the pretreatment step to operate properly with a discrete analyzer.
  • FIG. 3 shows an example of some workflows that can be accomplished by the invention. First, a sample 1 is obtained. The sample may be any liquid sample, for example beer, wort, blood or urine. The sample is identified by a data carrier such as a RFID chip or bar code and when the sample vessel enters the analyzer, data is read, or the sample can be identified to the system manually by the user, the sample is identified and the operating system of the analyzer requests all pretreatments and measurements that are to be performed on the sample. The sample may be placed on queue or taken directly forwards. Now the whole sample or more commonly one or more subsamples are taken from the sample by a metallic needleand the extracted liquid is placed on measurement wells, such as cuvettes.
  • If pretreatment is needed, the sample or subsample/aliquot is transferred to pretreatment step and pretreatment is performed as earlier has been descrided. In short, pretreatment includes capturing and releasing molecule that is to be measured in order to purify or enrich it. See description of pretreatment process for further details. Pretreatment should not change the chemical composition of the analyte. The pretreated sample is transferred to a measurement step. Some examples are shown in FIG. 3. In Application 1 the sample (herein a whole sample, alternatively a subsample) can be measured photometrically without any chemical reaction. In this example (ref * in figure), pretreatment is part of the Application and is automatically generated by requesting the Application 1. In practice this application consists of pretreatment step with flexibility to design pretreatment parameters and the actual measurement step. In this case measurement is performed with no reagent additions. Application 1 (ref **) can be for example beer/wort bitterness or polyphenol analysis.
  • Applications 2 and 3 include dispensing at least sample aliquot (subsample), dispensing reagent, incubation and photometric analysis. In Application 3, two or more reagents are used ( reagents 2, 3, 4, and 5).
  • When pretreatment step is not needed, sample or sample aliquot can be processed according to Applications 4-7. Now the sample/subsample (aliquot) is measured photometrically without reacting with a reagent (Application 4), measured electrochemically without adding reagent (Application 5) or by similar methods as in Applications 2 and 3 (Applications 6 and 7). The Applications shown here are examples only and any measurement process application available in analyzer may be used in conjuction with both pretreatment steps, i.e. together with actual pretreatment or directing the sample or subsample directly to measurement step.
  • Applications 2-7 can be for example Beta-Glucan, Glucose, pH, conductivity, hemoglobin, HbAlC analysis, Ammonia or sulphate measurements.
  • Several samples, and their replicates, can be assayed simultaneously with several applications.
  • Sample dispensing does not require disposable tips. Vice versa, disposable tips should be avoided in order to keep the operating costs at bay. Application examples can have flexibility for volumes, dispensing orders and incluce e.g additional sample blankings.
  • FIG. 4 shows one operating principle of the invention using an explanatory display template. Herein the process starts when client requests a test. This request can be delivered to the analyzer by a memory device or made manually when a sample is loaded to the analyzer. When a test is requested for a named sample, the analyzer automatically selects a pretreatment step including pretreatment or no pretreatment according to the specifications of the test as well as measurements, reagents, incubation time, mixing and other features. All parameters may be determined flexibly. The left side of the display shows a list of test and treatments available. Herein a test Bitter 300 is requested (highlighted). The list shows that the test is photometric and pretreatment is on use. On the right side is information about the test which shows that pretreatment method is Bitter AU. Further details about reagents, samples, incubation and such used in a particular test are placed under tabs with same nominations (now shown in this display). The flow of the test is displayed on the right side of the tabs.
  • As can be seen on the display, Bitter 300 request performs automatically a Bitter AU pretreatment (selection: Pretreatment procedure: Bitter AU) and thereafter a photometric test typical to a discrete analyzer. The parameters of the photometric test are placed under the tabs bearing nominations of the parameters.
  • Multiple tests may be performed on one sample. As can be seen on the left side of the display, the analyzer is capable of performing multiple different tests (see test name) simultaneously and some of the tests may include pretreatment and some not. A pretreatment step can also be performed without a following photometric test requiring additional reagents. Usually a subsample of the original or pretreated sample is needed for each test.
  • Various embodiments of the method according to the invention are capable of performing optional, on demand pretreatment, simultaneous measurement and pretreatment, and/or measurement. Pretreatment may be performed on a whole sample r subsample or sample aliquot of the whole sample. Several tests may be performed on a single sample. Sample or sample aliquot can also be automatically treated or e.g. adjusted for pH by reagent addition before pretreatment.
  • Numerous embodiments of the present invention have been shown and described with attention paid to fundamental novel features of the invention as applied to the embodiments. However, it is understood that various omissions and substitutions and changes in the form and details of the invention may be made by those skilled in the art without departing from the spirit of the invention. For example, it is expressly intended that all combinations of those elements which perform substantially the same results are within the scope of the invention. Substitutions of the elements from one described embodiment to another are also fully intended and contemplated. It is also to be understood that the drawings are not necessarily drawn to scale but they are merely conceptual in nature. It is the intention, therefore, to be limited only as indicated by the scope of the claims appended hereto.

Claims (31)

1. Method for pretreatment of a desired sample in a discrete fluid analyzing apparatus wherein handling and analysis of the sample is automated, comprising at least the steps of:
pretreating at least a subsample of said sample by retaining at least one substance or analyte from the sample via immobilization by a capture means wherefrom the substance or analyte is reversibly removable,
measuring at least one property of said subsample, and
simultaneously or consecutively directing any non-pretreated sample or any subsample directly to at least one measuring step.
2. Method according to claim 1, wherein the measurements are performed with a discrete fluid analyzer that performs chemical reactions and at least photometric measurements in separate wells.
3. Method according to claim 1, wherein at least one measurement is performed electrochemically.
4. Method according to claim 1, wherein pretreated sample or sample aliquot is measured unaltered after pretreatment.
5. Method according to claim 1, wherein at least an aliquot of pretreated sample is obtained, at least one reagent is dispensed thereto, the sample aliqout is incubated and analysed photometrically.
6. Method according to claim 5, comprising dispensing at least two reagents.
7. Method according to claim 1, comprising providing at least a subsample of a sample before pretreatment.
8. Method according to claim 7, wherein at least one measurement is performed electrochemically.
9. Method according to claim 7, wherein the analyte in the pretreated sample or sample aliquot is measured unaltered.
10. Method according to claim 7, wherein at least an aliquot of sample before pretreatment is obtained, at least one reagent is dispensed thereto, the sample aliqout is incubated and analysed photometrically.
11. Method according to claim 10, comprising dispensing at least two reagents.
12. Method according to claim 1, wherein samples and subsamples are transferred and dispensed using washable dispensers.
13. Method according to claim 1, wherein at least two different measurements are performed on a same sample simultaneously or consecutively.
14. Method accordsing to claim 1, comprising using an automated discrete photometric analyzing device for measurements and sample pretreatment wherein at least one substance of the sample matrix or analyte is retained.
15. Method according to claim 1, further comprising elution of the substance or analyte from the capture means prior to analysis.
16. Method according to the claim 15, further comprising elution and discarding of an analysis interfering substance.
17. Method according to claim 1, further comprising regeneration of the capture means.
18. Method according to claim 1, wherein the capture means is chemically inactive in relation to the substance or analyte.
19. Method according to claim 1, wherein said at least one substance or analyte is immobilized on a surface of the capture means.
20. Method according to claim 1, wherein the at least one substance or analyte is immobilized by binding to an antibody or other specifically binding substance.
21. Method according to claim 20, wherein said at least one substance or analyte is immobilized by binding to an antibody.
22. Method according to claim 1, wherein said at least one substance or analyte is immobilized by a filter.
23. Method according to the claim 21, wherein said filter is membrane filter for retaining molecules of determined size.
24. Method according to claim 1, wherein said analyte is immobilized from a first volume and said substance or analyte is eluted in a second volume that is smaller than the first volume.
25. Method according to claim 1, further including at least one of the following steps:
separating analytes from complex forming or binding molecules,
separating analytes from cell debris,
separating analytes from substances interfering with analyte detection,
desalting the sample,
exchanging the sample solvent,
separating analytes from matrix substances.
26. Method according to claim 1, wherein said immobilization of said substance or analyte is performed using at least one of following: reversible covalent bonding, ionic interaction, sieving or filtering (molecular size and shape, diffusion), polarity, hydrophobicity, molecule or group specific interaction and chiral recognition.
27. Apparatus for pretreatment of a desired sample in a discrete fluid analyzing instrument comprising automated means for handling and analyzing the sample, said apparatus comprising:
a means for performing a pretreatment step on the sample or a sub-sample of the sample,
a means for immobilizing at least one substance or analyte from the sample or sub-sample wherein the substance or analyte is reversibly immobilized,
a means for measuring at least one property of said sample or subsample, and
a means for simultaneously or consecutively directing any non-pretreated sample or any subsample directly to at least one measuring step.
28. Apparatus according to the claim 27, further comprising means for eluting the substance or analyte from the capture means prior to analysis.
29. Apparatus for performing the method according to claim 1, wherein means for immobilizing the substance or analyte is chemically inactive in relation to the substance or analyte.
30. Apparatus according to claim 27, comprising means for at least one of electrical measurements of photometric measurements.
31. Apparatus according to claim 27, comprising at least one washable dispensing means for transferring and handling an analyte.
US13/568,965 2011-08-08 2012-08-07 Method and apparatus for automated analysis Abandoned US20130040403A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US13/568,965 US20130040403A1 (en) 2011-08-08 2012-08-07 Method and apparatus for automated analysis
US15/681,702 US10845278B2 (en) 2011-08-08 2017-08-21 Method and apparatus for automated analysis
US17/073,426 US20210033503A1 (en) 2011-08-08 2020-10-19 Apparatus for automated analysis

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161515992P 2011-08-08 2011-08-08
FI20115785 2011-08-08
FI20115785A FI20115785A0 (en) 2011-08-08 2011-08-08 Method and apparatus for automatic analysis
US13/568,965 US20130040403A1 (en) 2011-08-08 2012-08-07 Method and apparatus for automated analysis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/681,702 Division US10845278B2 (en) 2011-08-08 2017-08-21 Method and apparatus for automated analysis

Publications (1)

Publication Number Publication Date
US20130040403A1 true US20130040403A1 (en) 2013-02-14

Family

ID=44515420

Family Applications (3)

Application Number Title Priority Date Filing Date
US13/568,965 Abandoned US20130040403A1 (en) 2011-08-08 2012-08-07 Method and apparatus for automated analysis
US15/681,702 Active 2033-08-01 US10845278B2 (en) 2011-08-08 2017-08-21 Method and apparatus for automated analysis
US17/073,426 Pending US20210033503A1 (en) 2011-08-08 2020-10-19 Apparatus for automated analysis

Family Applications After (2)

Application Number Title Priority Date Filing Date
US15/681,702 Active 2033-08-01 US10845278B2 (en) 2011-08-08 2017-08-21 Method and apparatus for automated analysis
US17/073,426 Pending US20210033503A1 (en) 2011-08-08 2020-10-19 Apparatus for automated analysis

Country Status (4)

Country Link
US (3) US20130040403A1 (en)
EP (2) EP2742362A1 (en)
FI (2) FI20115785A0 (en)
WO (1) WO2013021100A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150182877A1 (en) * 2012-07-25 2015-07-02 Hitachi High- Technologies Corporation Analysis device
EP3566771A1 (en) * 2018-05-09 2019-11-13 F. Hoffmann-La Roche AG Laboratory system and method for separating interfering substances contained in test samples

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110865197A (en) * 2018-08-27 2020-03-06 襄阳中诚检测科技有限公司 Method for analyzing discrete sample aliquots of analytes
CN110967412A (en) * 2018-09-28 2020-04-07 中国人民解放军军事科学院军事医学研究院 Pretreatment method for detecting food containing mycotoxin based on accelerated solvent extraction
CN114460706A (en) * 2022-02-24 2022-05-10 浙江舜宇光学有限公司 Split type lens and assembling method thereof

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764601A (en) * 1985-10-18 1988-08-16 The Ohio State University Research Foundation Composition for assaying cardiac glycosides from serum or plasma
US5116578A (en) * 1983-03-26 1992-05-26 Baxter James A Vial sleeve
US5439813A (en) * 1991-09-06 1995-08-08 E. I. Du Pont De Nemours And Company Production of glyoxylic acid with glycolate oxidase and catalase immobilized on oxirane acrylic beads
US5858974A (en) * 1995-07-20 1999-01-12 Xoma Corporation Anti-fungal peptides
US6344172B1 (en) * 1991-09-30 2002-02-05 Perseptive Biosystems, Inc. Protein chromatography system
US20040124128A1 (en) * 2002-12-25 2004-07-01 Yosuke Iwata Liquid chromatograph
WO2009121034A2 (en) * 2008-03-28 2009-10-01 Pelican Group Holdings, Inc. Multicapillary sample preparation devices and methods for processing analytes
US20100286114A1 (en) * 2007-12-13 2010-11-11 Siena Biotech S.P.A. Hedgehog pathway antagonists and therapeutic applications thereof
US20110070664A1 (en) * 2009-05-18 2011-03-24 Woolley Adam T Integrated Microfluidic Device for Serum Biomarker Quantitation using Either Standard Addition or a Calibration Curve
US20110275162A1 (en) * 2010-05-05 2011-11-10 Alverix, Inc. Assay reader operable to scan a test strip
US20120185177A1 (en) * 2009-02-20 2012-07-19 Hannon Gregory J Harnessing high throughput sequencing for multiplexed specimen analysis
US20120206713A1 (en) * 2009-10-16 2012-08-16 Hitachi High-Technologies Corporation Examination device and examination method
US20130040307A1 (en) * 2011-08-08 2013-02-14 Thermo Fisher Scientific Oy Method and apparatus for automated analysis

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1272638A (en) * 1969-05-22 1972-05-03 Shell Int Research Chromatographic apparatus
JPS5916667B2 (en) 1975-02-28 1984-04-17 トウアイヨウデンシ カブシキガイシヤ automatic blood analyzer
US4215563A (en) * 1976-07-15 1980-08-05 Phillips Petroleum Company Chromatographic analysis normalizer
US5260192A (en) * 1987-03-13 1993-11-09 Coulter Corporation Method and apparatus for screening cells or formed bodies with populations expressing selected characteristics utilizing at least one sensing parameter
US5030554A (en) 1987-12-04 1991-07-09 Coulter Corporation Conservative whole blood sample preparation technique
SE513881C2 (en) 1994-01-10 2000-11-20 Boule Medical Ab Method and apparatus for analyzing liquid samples
US5891734A (en) 1994-08-01 1999-04-06 Abbott Laboratories Method for performing automated analysis
US5812419A (en) * 1994-08-01 1998-09-22 Abbott Laboratories Fully automated analysis method with optical system for blood cell analyzer
US5656499A (en) 1994-08-01 1997-08-12 Abbott Laboratories Method for performing automated hematology and cytometry analysis
US6709869B2 (en) 1995-12-18 2004-03-23 Tecan Trading Ag Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system
WO1997046882A1 (en) 1996-06-07 1997-12-11 Immunivest Corporation Magnetic separation employing external and internal gradients
JP3582240B2 (en) * 1996-06-14 2004-10-27 東ソー株式会社 Automatic sample pretreatment device and automatic sample pretreatment method
JP3788909B2 (en) * 1999-02-12 2006-06-21 セテク コーポレイション A high-throughput size exclusion method for screening complex physiological materials for affinity ligands
US7588725B2 (en) * 2001-04-25 2009-09-15 Biotrove, Inc. High throughput autosampler
US6964872B2 (en) 2001-05-18 2005-11-15 Srl, Inc. Immunoassay method
DE10319045A1 (en) 2003-04-25 2004-12-09 november Aktiengesellschaft Gesellschaft für Molekulare Medizin Device and method for processing liquids containing biopolymers
US7485464B2 (en) 2003-04-30 2009-02-03 Westco Scientific Instruments, Inc. Method and apparatus for sample preparation in an automated discrete fluid sample analyzer
EP1682275A1 (en) * 2003-10-31 2006-07-26 Hansjörg Cueni Sample pipette
US7794659B2 (en) * 2005-03-10 2010-09-14 Gen-Probe Incorporated Signal measuring system having a movable signal measuring device
US20060275906A1 (en) 2005-06-03 2006-12-07 Devlin William J Sr Method for ascertaining interferents in small liquid samples in an automated clinical analyzer
US7763453B2 (en) 2005-11-30 2010-07-27 Micronics, Inc. Microfluidic mixing and analytic apparatus
US7790464B2 (en) 2006-05-04 2010-09-07 Blaze Medical Devices, LLC Blood hemolysis analyzer
US7735652B2 (en) 2006-06-01 2010-06-15 The Trustees Of Princeton University Apparatus and method for continuous particle separation
WO2007140961A1 (en) 2006-06-06 2007-12-13 Roche Diagnostics Gmbh Differential hemolysis of a whole blood sample
US7815803B2 (en) 2007-06-14 2010-10-19 Roche Diagnostics Operations, Inc. Preparation of samples for LC-MS/MS using magnetic particles
EP3181228B1 (en) 2007-10-02 2020-07-29 Labrador Diagnostics LLC Modular point-of-care devices and uses thereof
JP5097522B2 (en) * 2007-12-07 2012-12-12 株式会社日立ハイテクノロジーズ Automatic analyzer
WO2010033627A2 (en) * 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
US8481302B2 (en) 2008-11-03 2013-07-09 General Electric Company Total bacteria monitoring system
JP5519538B2 (en) * 2009-01-29 2014-06-11 株式会社日立ハイテクノロジーズ Sample pretreatment apparatus and mass spectrometer equipped with the same
US9207152B2 (en) * 2009-06-25 2015-12-08 Hitachi High-Technologies Corporation Pretreatment apparatus and mass analyzing apparatus equipped with the same
CN102472692B (en) 2009-08-10 2015-01-07 株式会社日立高新技术 Specimen processing system
US9034658B2 (en) 2009-11-23 2015-05-19 The General Hospital Corporation Microfluidic devices for the capture of biological sample components
DE202011111050U1 (en) 2010-10-29 2018-11-20 Thermo Fisher Scientific Oy Automated system for sample preparation and analysis

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116578A (en) * 1983-03-26 1992-05-26 Baxter James A Vial sleeve
US4764601A (en) * 1985-10-18 1988-08-16 The Ohio State University Research Foundation Composition for assaying cardiac glycosides from serum or plasma
US5439813A (en) * 1991-09-06 1995-08-08 E. I. Du Pont De Nemours And Company Production of glyoxylic acid with glycolate oxidase and catalase immobilized on oxirane acrylic beads
US6344172B1 (en) * 1991-09-30 2002-02-05 Perseptive Biosystems, Inc. Protein chromatography system
US5858974A (en) * 1995-07-20 1999-01-12 Xoma Corporation Anti-fungal peptides
US20040124128A1 (en) * 2002-12-25 2004-07-01 Yosuke Iwata Liquid chromatograph
US20100286114A1 (en) * 2007-12-13 2010-11-11 Siena Biotech S.P.A. Hedgehog pathway antagonists and therapeutic applications thereof
WO2009121034A2 (en) * 2008-03-28 2009-10-01 Pelican Group Holdings, Inc. Multicapillary sample preparation devices and methods for processing analytes
US20120185177A1 (en) * 2009-02-20 2012-07-19 Hannon Gregory J Harnessing high throughput sequencing for multiplexed specimen analysis
US20110070664A1 (en) * 2009-05-18 2011-03-24 Woolley Adam T Integrated Microfluidic Device for Serum Biomarker Quantitation using Either Standard Addition or a Calibration Curve
US20120206713A1 (en) * 2009-10-16 2012-08-16 Hitachi High-Technologies Corporation Examination device and examination method
US20110275162A1 (en) * 2010-05-05 2011-11-10 Alverix, Inc. Assay reader operable to scan a test strip
US20130040307A1 (en) * 2011-08-08 2013-02-14 Thermo Fisher Scientific Oy Method and apparatus for automated analysis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Merriam Webster 1998 *
Reynolds (2003) Clin Chem 49: (10) p 1733 - 1739 *
Reynolds (2003) Clin Chem 49: 1733-1739 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150182877A1 (en) * 2012-07-25 2015-07-02 Hitachi High- Technologies Corporation Analysis device
US9597612B2 (en) * 2012-07-25 2017-03-21 Hitachi High-Technologies Corporation Analysis device including solid-phase extraction material filling and discharging mechanisms
EP3566771A1 (en) * 2018-05-09 2019-11-13 F. Hoffmann-La Roche AG Laboratory system and method for separating interfering substances contained in test samples
JP2019197052A (en) * 2018-05-09 2019-11-14 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Inspection chamber system and method for separating interference substance contained in test sample
CN110470852A (en) * 2018-05-09 2019-11-19 豪夫迈·罗氏有限公司 Laboratory system and method for the interfering substance for including in separation test sample
US11747244B2 (en) 2018-05-09 2023-09-05 Roche Diagnostics Operations, Inc. Laboratory system and method for separating interfering substances contained in test samples
JP7361492B2 (en) 2018-05-09 2023-10-16 エフ． ホフマン－ラ ロシュ アーゲー Laboratory systems and methods for separating interfering substances contained in test samples

Also Published As

Publication number Publication date
US20180128721A1 (en) 2018-05-10
WO2013021100A1 (en) 2013-02-14
US10845278B2 (en) 2020-11-24
EP2742362A1 (en) 2014-06-18
FI20115785A0 (en) 2011-08-08
US20210033503A1 (en) 2021-02-04
FI20125401L (en) 2013-02-09
EP2742354A1 (en) 2014-06-18

Similar Documents

Publication Publication Date Title
US20210033503A1 (en) Apparatus for automated analysis
US10876939B2 (en) Apparatus for automated analysis
US8278108B2 (en) Automatic analyzer
WO2009157353A1 (en) Nucleic acid analyzer, automatic analyzer, and analysis method
ZA200600492B (en) Method for increasing capacity in an automatic clinical analyzer by using modular reagent delivery means
JP2016536590A (en) Multiwell cuvette with integrated reaction and detection means
JP7361492B2 (en) Laboratory systems and methods for separating interfering substances contained in test samples
WO2005008217A9 (en) Method for increasing capacity in an automatic clinical analyzer by using modular reagent delivery means
JP6120763B2 (en) Apparatus and process for transporting reaction vessel
JP3380542B2 (en) Biological sample analysis method
Wells et al. Automation of sample preparation for pharmaceutical and clinical analysis
Thurow Strategies for automating analytical and bioanalytical laboratories
US20220326271A1 (en) Methods for onboard dilutions using automated analyzer
WO2020225971A1 (en) Automatic analysis device pretreatment method
EP4184175A1 (en) Laboratory instrument
Stone et al. A User-Friendly Sample Preparation Alternative for Manual and Automated LC-MS/MS Quantification of Testosterone
Dutt et al. Semi-Automated Lectin Magnetic Bead Array (LeMBA) for Translational Serum Glycoprotein Biomarker Discovery and Validation
CN117769653A (en) Integrated sample preparation and analysis system
EP4272004A1 (en) Integrated automated analyzer and methods of analyzing whole blood and plasma from a single sample tube
Saunders et al. 9 Automation of Sample Preparation
JPH03255955A (en) Catechol amine metabolyte analyzing apparatus

Legal Events

Date Code Title Description
AS Assignment

Owner name: THERMO FISHER SCIENTIFIC OY, FINLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TIKANOJA, SARI;SUONIEMI-KAHARA, ANNU;FINELL, JOHAN;SIGNING DATES FROM 20120921 TO 20121002;REEL/FRAME:029135/0348

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION